305 related articles for article (PubMed ID: 32844132)
1. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection.
Hariyanto TI; Kurniawan A
Obes Med; 2020 Sep; 19():100290. PubMed ID: 32844132
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.
Hariyanto TI; Kurniawan A
Diabetes Metab Syndr; 2020; 14(6):1613-1615. PubMed ID: 32882643
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Intan D; Hananto JE; Putri C; Kurniawan A
Diabetes Res Clin Pract; 2021 Sep; 179():109031. PubMed ID: 34461139
[TBL] [Abstract][Full Text] [Related]
5. Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Kurniawan A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1662-1670. PubMed ID: 33838992
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.
Hariyanto TI; Kurniawan A
Diabetes Metab Syndr; 2020; 14(5):1463-1465. PubMed ID: 32771919
[TBL] [Abstract][Full Text] [Related]
7. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis.
Hariyanto TI; Putri C; Arisa J; Situmeang RFV; Kurniawan A
Arch Gerontol Geriatr; 2021; 93():104299. PubMed ID: 33285424
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Kurniawan A
J Diabetes Metab Disord; 2021 Jun; 20(1):543-550. PubMed ID: 33816358
[TBL] [Abstract][Full Text] [Related]
9. Insulin Therapy and Outcome of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.
Hariyanto TI; Lugito NPH; Yanto TA; Siregar JI; Kurniawan A
Endocr Metab Immune Disord Drug Targets; 2022; 22(5):481-489. PubMed ID: 34250875
[TBL] [Abstract][Full Text] [Related]
10. Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.
Poly TN; Islam MM; Li YJ; Lin MC; Hsu MH; Wang YC
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441802
[TBL] [Abstract][Full Text] [Related]
11. Anosmia/Hyposmia is a Good Predictor of Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis.
Hariyanto TI; Rizki NA; Kurniawan A
Int Arch Otorhinolaryngol; 2021 Jan; 25(1):e170-e174. PubMed ID: 33552295
[No Abstract] [Full Text] [Related]
12. Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis.
Hariyanto TI; Hardyson W; Kurniawan A
Drug Res (Stuttg); 2021 May; 71(5):265-274. PubMed ID: 33401328
[TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
Hariyanto TI; Putri C; Frinka P; Louisa J; Lugito NPH; Kurniawan A
AIDS Res Hum Retroviruses; 2021 Jan; ():. PubMed ID: 33499744
[TBL] [Abstract][Full Text] [Related]
14. Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis.
Li Y; Yang X; Yan P; Sun T; Zeng Z; Li S
Front Med (Lausanne); 2021; 8():704666. PubMed ID: 34490296
[No Abstract] [Full Text] [Related]
15. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
Ma Z; Krishnamurthy M
PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
[TBL] [Abstract][Full Text] [Related]
17. Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Putri C; Hananto JE; Arisa J; Fransisca V Situmeang R; Kurniawan A
J Psychiatr Res; 2021 Oct; 142():361-368. PubMed ID: 34425488
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis.
Hariyanto TI; Kurniawan A
Sleep Med; 2021 Jun; 82():47-53. PubMed ID: 33892451
[TBL] [Abstract][Full Text] [Related]
19. Association between viral hepatitis and increased risk of severe coronavirus disease 2019 (COVID-19) outcome: a systematic review and meta-analysis.
Hariyanto TI; Jodhinata C; Halim DA; Kurniawan A
Gastroenterol Hepatol Bed Bench; 2022; 15(1):9-14. PubMed ID: 35611257
[TBL] [Abstract][Full Text] [Related]
20. Pre-Admission Beta-Blocker Therapy and Outcomes of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.
Hariyanto TI; Hananto JE; Intan D; Kurniawan A
Cardiovasc Hematol Disord Drug Targets; 2022; 22(2):104-117. PubMed ID: 35450537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
